European Archives - Page 370 of 1132 - European Medical Journal

EMJ Oncology 11 [Supplement 5] 2023

Incidence and mortality rates of endometrial cancer, the most common gynaecological cancer in high-income countries, are increasing…

Disparities in the Incidence and Outcome of Endometrial Cancer: Interviews with Two Key Opinion Leaders

Endometrial cancer is one of the most common gynaecological cancers in high-income countries, and often presents with comorbidities…

Interview: John Marshall

You have to remember that I am a very old oncologist. So, when I first started, there was almost nothing in the world of GI cancer. I was…

Advancements in NSCLC: In Pursuit of a Life for Every Patient

Tune in to our latest podcast for valuable insights on non-small cell lung cancer (NSCLC). Esteemed contributors to this discussion include…

Does Testosterone Replacement Improve Steatotic Liver Disease?

Male hypogonadism is associated with visceral obesity and metabolic syndrome. The present study aims to compare the effects of testosterone treatment with a placebo in treating non-alcoholic fatty liver disease in older hypogonadal males.

Changing the tide on health inequities

Listen to Marion Brooks, Vice President and US Country Head, Diversity, Equality and Inclusion, Novartis discussing diversity, equity and inclusion.

Novel Scoring Tool Predicts Alcoholic Relapse Following Liver Transplant

New data suggests that the risk of alcoholic relapse in patients with alcohol-related liver disease who underwent liver transplant may be more accurately determined with the help of a new scoring system.

Protecting the informed patient from misinformation

Read about the role the pharma industry can play in ensuring patients can access the right information about medical conditions and medicines.

Longer Prostatic Urethra Increases Risk of Adverse Events Following Radiation Therapy

Detected on MRI, increased prostatic urethral length has been shown to increase risk of adverse events following radiation therapy for prostate cancer. Read more.

Improved Survival from Radical Prostatectomy in Patients with High-Risk Localised Prostate Cancer

An observational study from the University of California, San Francisco, USA discovered that one option for treating high-risk localised prostate cancer showing favourable survival outcomes is radical prostatectomy.